1. Home
  2. LPCN vs GYRO Comparison

LPCN vs GYRO Comparison

Compare LPCN & GYRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • GYRO
  • Stock Information
  • Founded
  • LPCN 1997
  • GYRO 1946
  • Country
  • LPCN United States
  • GYRO United States
  • Employees
  • LPCN N/A
  • GYRO N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • GYRO Building operators
  • Sector
  • LPCN Health Care
  • GYRO Real Estate
  • Exchange
  • LPCN Nasdaq
  • GYRO Nasdaq
  • Market Cap
  • LPCN 19.4M
  • GYRO 20.4M
  • IPO Year
  • LPCN N/A
  • GYRO N/A
  • Fundamental
  • Price
  • LPCN $3.38
  • GYRO $8.90
  • Analyst Decision
  • LPCN Strong Buy
  • GYRO
  • Analyst Count
  • LPCN 1
  • GYRO 0
  • Target Price
  • LPCN $10.00
  • GYRO N/A
  • AVG Volume (30 Days)
  • LPCN 33.0K
  • GYRO 484.0
  • Earning Date
  • LPCN 03-06-2025
  • GYRO 01-01-0001
  • Dividend Yield
  • LPCN N/A
  • GYRO N/A
  • EPS Growth
  • LPCN N/A
  • GYRO N/A
  • EPS
  • LPCN N/A
  • GYRO N/A
  • Revenue
  • LPCN $7,922,926.00
  • GYRO $2,738,019.00
  • Revenue This Year
  • LPCN N/A
  • GYRO N/A
  • Revenue Next Year
  • LPCN N/A
  • GYRO N/A
  • P/E Ratio
  • LPCN N/A
  • GYRO N/A
  • Revenue Growth
  • LPCN N/A
  • GYRO N/A
  • 52 Week Low
  • LPCN $3.20
  • GYRO $7.65
  • 52 Week High
  • LPCN $11.79
  • GYRO $11.96
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 30.99
  • GYRO 39.74
  • Support Level
  • LPCN $3.42
  • GYRO $8.90
  • Resistance Level
  • LPCN $3.62
  • GYRO $9.50
  • Average True Range (ATR)
  • LPCN 0.26
  • GYRO 0.05
  • MACD
  • LPCN -0.02
  • GYRO -0.02
  • Stochastic Oscillator
  • LPCN 1.61
  • GYRO 19.64

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.

About GYRO Gyrodyne LLC

Gyrodyne LLC is a United States-based limited liability company. It operates in the ownership and management of industrial and medical office buildings segment. The company leases and manages various commercial properties such as medical offices and industrial properties. The properties owned by the company include Cortlandt Manor and Flowerfield.

Share on Social Networks: